Available to sourceHuman Prescription DrugCardiovascular

FILSPARI (sparsentan)

400 mg/1 · Film-Coated Tablet

By Travere Therapeutics, Inc.

NDC: 68974-400
Route: Oral
Therapeutic class: Angiotensin 2 Receptor Blocker , Angiotensin 2 Type 1 Receptor Antagonists [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Endothelin Receptor Antagonist , Endothelin Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]
Marketing category: NDA

Package sizes

30 TABLET, FILM COATED in 1 BOTTLE (68974-400-30)NDC 68974-400-30Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Related in Cardiovascular

See all →

FILSPARI (sparsentan)

Package sizes

Additional information

Request this medication

Related in Cardiovascular

Multivitamin with Fluoride

Multivitamin with Fluoride

Multivitamin with Fluoride

Multivitamin with Fluoride